Condition: Leukemia, Myeloid, Acute · Sponsor: Zhujiang Hospital
The goal of this clinical research study is to learn if azacitidine combined with Chidamide will help to control the disease in patients with high-risk AML after an allogeneic stem cell transplant. The safety of this combination will also be studied.
This description comes directly from the study's public registry record.
Rui Huang, Doctor · +8615918528317 · Rachelchn@163.com
Yunqing Wang, Bachelor · +8618585509970 · Wangyun7q@163.com
Always discuss trial participation with your own doctor first.
| Nanfang Hospital of Southern Medical University | Guanzhou, Guandong, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05270200